These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34871054)

  • 21. Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy.
    Rhoades R; Leong R; Kopenitz J; Thoma B; McDermott L; Dovidio J; Barletti S; Gong JZ; Massey HT; McKenzie SE; Rame JE; Al-Rawas N
    Thromb Res; 2021 Jul; 203():1-4. PubMed ID: 33894473
    [No Abstract]   [Full Text] [Related]  

  • 22. Gastrointestinal bleeding and endoscopic findings in critically and non-critically ill patients with corona virus disease 2019 (COVID-19): Results from Lean European Open Survey on SARS-CoV-2 (LEOSS) and COKA registries.
    Zellmer S; Hanses F; Muzalyova A; Classen J; Braun G; Piepel C; Erber J; Pilgram L; Walter L; Göpel S; Wille K; Hower M; Rüthrich MM; Rupp J; Degenhardt C; Voigt I; Borgmann S; Stecher M; Jakob C; Dhillon C; Messmann H; Ebigbo A; Römmele C;
    United European Gastroenterol J; 2021 Nov; 9(9):1081-1090. PubMed ID: 34655180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment.
    Allione A; Giamello JD; Paglietta G; Bernardi S; Cavalot G
    Intern Emerg Med; 2021 Mar; 16(2):519-520. PubMed ID: 32440985
    [No Abstract]   [Full Text] [Related]  

  • 24. [COVID-19, anticoagulation and venous thromboembolism: what have we learned ?].
    Blondon M; Robert-Ebadi H
    Rev Med Suisse; 2021 Dec; 17(762):2140-2144. PubMed ID: 34878743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Albumin Infusion in Critically Ill COVID-19 Patients: Hemodilution and Anticoagulation.
    Ramadori G
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The single-dose J&J vaccine had 67% efficacy against moderate to severe-critical COVID-19 at ≥14 d.
    Sacks HS
    Ann Intern Med; 2021 Jul; 174(7):JC75. PubMed ID: 34224270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients.
    Obi AT; Tignanelli CJ; Jacobs BN; Arya S; Park PK; Wakefield TW; Henke PK; Napolitano LM
    J Vasc Surg Venous Lymphat Disord; 2019 May; 7(3):317-324. PubMed ID: 30477976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Learning with COVID-19: what about anticoagulation?].
    Álvarez-Rodríguez E; González González R; Torres-Gárate R; López-Riquelme P; González Martil I; Abad Cuñado V
    An Sist Sanit Navar; 2020 Aug; 43(2):251-254. PubMed ID: 32865189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.
    Zarbock A; Küllmar M; Kindgen-Milles D; Wempe C; Gerss J; Brandenburger T; Dimski T; Tyczynski B; Jahn M; Mülling N; Mehrländer M; Rosenberger P; Marx G; Simon TP; Jaschinski U; Deetjen P; Putensen C; Schewe JC; Kluge S; Jarczak D; Slowinski T; Bodenstein M; Meybohm P; Wirtz S; Moerer O; Kortgen A; Simon P; Bagshaw SM; Kellum JA; Meersch M;
    JAMA; 2020 Oct; 324(16):1629-1639. PubMed ID: 33095849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Need for Chemo-Thromboprophylaxis Protocols in Critically Ill COVID-19 Patients.
    Ehrlich H; McKenney M; Elkbuli A
    Am Surg; 2021 May; 87(5):698-699. PubMed ID: 33283541
    [No Abstract]   [Full Text] [Related]  

  • 31. Heparin-induced hyponatremia in COVID-19: A latent culprit!
    Panda R; Singh P; Kodamanchili S; Anand A
    Indian J Pharmacol; 2021; 53(6):515-516. PubMed ID: 34975143
    [No Abstract]   [Full Text] [Related]  

  • 32. Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?
    de Montmollin E; Faille D; Andrieu V; Ajzenberg N; Timsit JF
    J Infect; 2021 May; 82(5):e20-e22. PubMed ID: 33549626
    [No Abstract]   [Full Text] [Related]  

  • 33. The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose.
    Chagla Z
    Ann Intern Med; 2021 Feb; 174(2):JC15. PubMed ID: 33524290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Re: 'Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review' by Serafim et al.
    Lipes J; Yang SS
    Clin Microbiol Infect; 2021 Jun; 27(6):938-939. PubMed ID: 33484842
    [No Abstract]   [Full Text] [Related]  

  • 35. A survey on acute kidney injury in severely and critically ill COVID-19 patients without chronic kidney disease.
    Yu Y; Ge H; Wang X; Huang Z; Chen L; Han Y; Jiang D; Tao L; Zhou Q; Peng Z; Xiao X
    Ann Palliat Med; 2021 Jun; 10(6):6198-6207. PubMed ID: 34044555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critically Ill
    Hong W; Chen Q; Qian S; Basharat Z; Zimmer V; Wang Y; Zippi M; Pan J
    Front Cell Infect Microbiol; 2021; 11():550456. PubMed ID: 34327146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of critical illness and organ failure on therapeutic argatroban dosage requirements in patients with suspected or confirmed heparin-induced thrombocytopenia.
    Keegan SP; Gallagher EM; Ernst NE; Young EJ; Mueller EW
    Ann Pharmacother; 2009 Jan; 43(1):19-27. PubMed ID: 19116377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In COVID-19, therapeutic vs. prophylactic anticoagulation did not improve clinical outcomes and increased bleeding.
    Diep R; Garcia D
    Ann Intern Med; 2021 Oct; 174(10):JC112. PubMed ID: 34606319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Letter in response to: Alamer A, Alrashed AA, Alfaifi M, et al. Effectiveness and safety of favipiravir compared to supportive care in moderately to critically ill COVID-19 patients: a retrospective study with propensity score matching sensitivity analysis. Curr Med Res Opin. 2021;19:1-13. DOI: 10.1080/03007995.2021.1920900.
    Dhanasekaran S; Chinnairusan M; Kagithakara Vajravelu L
    Curr Med Res Opin; 2022 Mar; 38(3):355-356. PubMed ID: 34933646
    [No Abstract]   [Full Text] [Related]  

  • 40. Heparin-Induced Thrombocytopenia in Severe COVID-19.
    Daviet F; Guervilly C; Baldesi O; Bernard-Guervilly F; Pilarczyk E; Genin A; Lefebvre L; Forel JM; Papazian L; Camoin-Jau L
    Circulation; 2020 Nov; 142(19):1875-1877. PubMed ID: 32990022
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.